LC
CC icon

Lindbrook Capital’s Chemours CC Stock Holding History

Lindbrook Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$10.5K Buy
778
+16
+2% +$266 ﹤0.01% 1630
2024
Q4 		$12.9K Buy
762
+146
+24% +$2.84K ﹤0.01% 1514
2024
Q3 		$12.5K Buy
616
+178
+41% +$3.64K ﹤0.01% 1555
2024
Q2 		$9.89K Sell
438
-98
-18% -$2.57K ﹤0.01% 1635
2024
Q1 		$14.1K Buy
536
+37
+7% +$1.05K ﹤0.01% 1384
2023
Q4 		$15.7K Sell
499
-537
-52% -$14.6K ﹤0.01% 1315
2023
Q3 		$29.1K Buy
1,036
+34
+3% +$1.17K ﹤0.01% 886
2023
Q2 		$37K Sell
1,002
-22
-2% -$671 ﹤0.01% 817
2023
Q1 		$30.7K Buy
1,024
+55
+6% +$1.81K ﹤0.01% 877
2022
Q4 		$29.7K Buy
969
+523
+117% +$15.7K ﹤0.01% 888
2022
Q3 		$11K Hold
446
– – ﹤0.01% 1269
2022
Q2 		$14K Hold
446
– – ﹤0.01% 1119
2022
Q1 		$14K Buy
446
+49
+12% +$1.53K ﹤0.01% 1146
2021
Q4 		$13K Buy
397
+166
+72% +$5.17K ﹤0.01% 1158
2021
Q3 		$7K Sell
231
-23
-9% -$745 ﹤0.01% 1115
2021
Q2 		$9K Buy
254
+23
+10% +$762 ﹤0.01% 1076
2021
Q1 		$6K Hold
231
– – ﹤0.01% 1192
2020
Q4 		$6K Hold
231
– – ﹤0.01% 1099
2020
Q3 		$5K Hold
231
– – ﹤0.01% 1092
2020
Q2 		$4K Hold
231
– – ﹤0.01% 1136
2020
Q1 		$2K Buy
231
+26
+13% +$375 ﹤0.01% 1268
2019
Q4 		$4K Hold
205
– – ﹤0.01% 1136
2019
Q3 		$3K Sell
205
-288
-58% -$4.68K ﹤0.01% 1156
2019
Q2 		$11K Hold
493
– – ﹤0.01% 856
2019
Q1 		$18K Buy
493
+96
+24% +$3.49K 0.01% 729
2018
Q4 		$11K Buy
+397
New +$12.6K 0.01% 801

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Lindbrook Capital's CC Position: Q1 2025 in Review

Lindbrook Capital increased its Chemours (CC) stake by 2.1% in Q1 2025, buying an estimated $266 and bringing the position to 778 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1630.

Lindbrook Capital first reported a position in CC in Q4 2018 and has held it in 26 quarters since. The position peaked at $37K in Q2 2023. 419 funds tracked by Wall St. Rank hold CC as of Q1 2025.

  • Lindbrook Capital held 778 shares of Chemours worth $10.5K as of Q1 2025.
  • Lindbrook Capital bought 16 Chemours shares in Q1 2025, an estimated $266.
  • Chemours made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1630 holding.
  • Lindbrook Capital first reported a position in Chemours in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Chemours position peaked at $37K in Q2 2023.
  • 419 funds tracked by Wall St. Rank held Chemours as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.